Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Ansseau

Showing results (201-210 of 267) with videos related to

Pageof 27
Sort By:
Psychoneuroendocrinology|March 27, 2007
Plasma oxytocin levels and anxiety in patients with major depressionG Scantamburlo, M Hansenne, S Fuchs, et al.
Psychoneuroendocrinology|June 21, 2005
AVP- and OT-neurophysins response to apomorphine and clonidine in major depressionG Scantamburlo, M Hansenne, S Fuchs, et al.
Psychiatry Research|November 1, 1984
Use of saliva cortisol in the dexamethasone suppression testM Ansseau, J Sulon, A Doumont, et al.
Psychoneuroendocrinology|January 1, 1987
Intranasal oxytocin in obsessive-compulsive disorderM Ansseau, J J Legros, C Mormont, et al.
Psychoneuroendocrinology|November 1, 1992
Apomorphine stimulation of vasopressin- and oxytocin-neurophysins. Evidence for increased oxytocinergic and decreased vasopressinergic function in schizophrenicsJ J Legros, C Gazzotti, T Carvelli, et al.
Human Psychopharmacology|October 31, 2002
Tianeptine and paroxetine in major depressive disorder, with a special focus on the anxious component in depression: an international, 6-week double-blind study daggerJean Pierre Lepine, Carlo Altamura, Marc Ansseau, et al.
Psychoneuroendocrinology|January 1, 1985
Diagnostic performance of the thirty-four hour dexamethasone suppression testM Ansseau, A Doumont, J L Cerfontaine, et al.
BMC Psychiatry|August 28, 2014
The downward spiral of mental disorders and educational attainment: a systematic review on early school leavingPascale Esch, Valéry Bocquet, Charles Pull, et al.
Analytical and Bioanalytical Chemistry|May 9, 2018
Affinity capillary electrophoresis for identification of active drug candidates in myotonic dystrophy type 1Ioan O Neaga, Stephanie Hambye, Ede Bodoki, et al.
Journal of Clinical Psychopharmacology|December 1, 1985
Extrapyramidal signs following zimelidine overdoseM Ansseau, C F Reynolds, D J Kupfer, et al.
Pageof 27

Showing results (201-210 of 267) with videos related to

Sort By:
Pageof 27
Psychoneuroendocrinology|March 27, 2007
Plasma oxytocin levels and anxiety in patients with major depressionG Scantamburlo, M Hansenne, S Fuchs, et al.
Psychoneuroendocrinology|June 21, 2005
AVP- and OT-neurophysins response to apomorphine and clonidine in major depressionG Scantamburlo, M Hansenne, S Fuchs, et al.
Psychiatry Research|November 1, 1984
Use of saliva cortisol in the dexamethasone suppression testM Ansseau, J Sulon, A Doumont, et al.
Psychoneuroendocrinology|January 1, 1987
Intranasal oxytocin in obsessive-compulsive disorderM Ansseau, J J Legros, C Mormont, et al.
Psychoneuroendocrinology|November 1, 1992
Apomorphine stimulation of vasopressin- and oxytocin-neurophysins. Evidence for increased oxytocinergic and decreased vasopressinergic function in schizophrenicsJ J Legros, C Gazzotti, T Carvelli, et al.
Human Psychopharmacology|October 31, 2002
Tianeptine and paroxetine in major depressive disorder, with a special focus on the anxious component in depression: an international, 6-week double-blind study daggerJean Pierre Lepine, Carlo Altamura, Marc Ansseau, et al.
Psychoneuroendocrinology|January 1, 1985
Diagnostic performance of the thirty-four hour dexamethasone suppression testM Ansseau, A Doumont, J L Cerfontaine, et al.
BMC Psychiatry|August 28, 2014
The downward spiral of mental disorders and educational attainment: a systematic review on early school leavingPascale Esch, Valéry Bocquet, Charles Pull, et al.
Analytical and Bioanalytical Chemistry|May 9, 2018
Affinity capillary electrophoresis for identification of active drug candidates in myotonic dystrophy type 1Ioan O Neaga, Stephanie Hambye, Ede Bodoki, et al.
Journal of Clinical Psychopharmacology|December 1, 1985
Extrapyramidal signs following zimelidine overdoseM Ansseau, C F Reynolds, D J Kupfer, et al.
Pageof 27